The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index; 4 of the 126 sources its claims cite were checked for support.
Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused?
Open accessAbstract
The term lipotoxicity elicits visions of steatotic liver, fat laden skeletal muscles and engorged lipid droplets that spawn a number of potentially harmful intermediates that can wreak havoc on signal transduction and organ function. Prominent among these so-called lipotoxic mediators are signaling molecules such as long chain acyl-CoAs, ceramides and diacyglycerols; each of which is thought to engage serine kinases that disrupt the insulin signaling cascade, thereby causing insulin resistance. Defects in skeletal muscle fat oxidation have been implicated as a driving factor contributing to systemic lipid imbalance, whereas exercise-induced enhancement of oxidative potential is considered protective. The past decade of diabetes research has focused heavily on the foregoing scenario, and indeed the model is grounded in strong experimental evidence, albeit largely correlative. This review centers on mechanisms that connect lipid surplus to insulin resistance in skeletal muscle, as well as those that underlie the antilipotoxic actions of exercise. Emphasis is placed on recent studies that challenge accepted paradigms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
84 Not checked yet · 27 Own interpretation · 11 No basis given · 1 Supported · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“these redox circuits intersect and regulate insulin signaling molecules such as PTEN, SHIP2 and PTP1B [14,38,44,45].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 5. Mitochondrial dysfunction and insulin resistance: A matter of definition?
What the sources say
- Partly supportedcites [14] Brandes, 2009, Thiol-based redox switches in eukaryotic proteins, Antioxid. Redox Signal. sourceExperimental — accuracy not yet measured
The sections on redox-regulated signaling and PTP1B describe oxidation of PTEN and insulin-induced oxidation of PTP1B; the PTP1B section also says glutathione can restore its phosphatase activity. Our copy does not identify SHIP2 as a target or establish that glutathione and thioredoxin circuits together regulate all three named molecules (searched: SHIP2 and thioredoxin with the named targets). (LLM, conf=0.85)
- Partly supportedcites [38] Hui, 2008, Txnip balances metabolic and growth signaling via PTEN disulfide reduction, Proc. Natl. Acad. Sci. U.S.A. sourceExperimental — accuracy not yet measured
The Results and Abstract describe thioredoxin-dependent reduction of PTEN and its effect on insulin/Akt signaling. The passages do not establish regulation of SHIP2 or PTP1B, or the involvement of glutathione circuits; searches for those terms yielded no supporting passage. No page numbers are available in our copy. (LLM, conf=0.88)
- Not checked yetcites [44] Jones, 2006, Disruption of mitochondrial redox circuitry in oxidative stress, Chem. Biol. Interact. source
- Partly supportedcites [45] Jones, 2008, Radical-free biology of oxidative stress, Am. J. Physiol. Cell Physiol. sourceExperimental — accuracy not yet measured
In its discussion of receptor activation pathways (section labeled Abstract; page unavailable), the paper describes GSH- and Trx-dependent redox control and identifies PTen and PTP-1B as redox-sensitive phosphatases. It names SHP2, not SHIP2, and discusses receptor tyrosine kinase signaling rather than specifically insulin signaling. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This phenomenon, now well known as the “athletes' paradox”, suggested that lipid droplet accumulation per se is not sufficient to disrupt insulin action.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 2. Intramuscular lipids, insulin resistance and the athletes' paradox
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“cross-sectional studies showing that isolated muscle strips, tissue homogenates or cultured myocytes from severely obese and/or diabetic humans exhibit diminished rates of fat oxidation when compared to specimens derived from healthy control subjects [9,41,46,87].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 2. Intramuscular lipids, insulin resistance and the athletes' paradox
What the sources say
- Not checked yetcites [9] Blaak, 2004, Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus, Proc. Nutr. Soc. source
- Not checked yetcites [41] Hulver, 2003, Skeletal muscle lipid metabolism with obesity, Am. J. Physiol. Endocrinol. Metab. source
- Not checked yetcites [46] Kelley, 1999, Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss, Am. J. Physiol.
- Not checked yetcites [87] Ukropcova, 2005, Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor, J. Clin. Invest. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“reports showing that lipid droplet accumulation in highly insulin-sensitive endurance athletes is similar to or even greater than that found in patients with type 2 diabetes [27,89,90].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 2. Intramuscular lipids, insulin resistance and the athletes' paradox
What the sources say
- Not checked yetcites [27] Goodpaster, 2001, Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes, J. Clin. Endocrinol. Metab. source
- Not checked yetcites [89] van Loon, 2006, Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state, Pflugers Arch. source
- Not checked yetcites [90] van Loon, 2004, Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes, Am. J. Physiol. Endocrinol. Metab. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Conversely, a generalized limitation in oxidative capacity or a specific impingement of β-oxidation necessitates a compensatory increase in glucose uptake and glycolytic ATP production.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 3. Mitochondrial dysfunction: Cause or consequence of metabolic disease?
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“diet-induced and genetic forms of glucose intolerance were associated with high rates of incomplete fat oxidation [49,50]”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 4. Fat oxidation: Friend or foe?
What the sources say
- Not checked yetcites [49] Koves, 2005, Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency, J. Biol. Chem. source
- Not checked yetcites [50] Koves, 2008, Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance, Cell Metab. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“the widely accepted chemiosmotic model of respiration [75], which holds that absolute rates of fuel oxidation under aerobic conditions depend ultimately on ATP turnover (i.e., workload).”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 3. Mitochondrial dysfunction: Cause or consequence of metabolic disease?
What the sources say
- Not checked yetcites [75] Rich, 2008, A perspective on Peter Mitchell and the chemiosmotic theory, J. Bioenerg. Biomembr. source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In the context of exercise, increased lipid delivery and catabolism allows for glucose/glycogen sparing, which then permits prolonged activity at a given submaximal intensity and/or a burst of anaerobic output in the later stages of an event [35].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 3. Mitochondrial dysfunction: Cause or consequence of metabolic disease?
What the sources say
- Not checked yetcites [35] Holloszy, 1984, Adaptations of skeletal muscle to endurance exercise and their metabolic consequences, J. Appl. Physiol. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, a large body of evidence predicts that a deficit in β- oxidation would increase, not decrease, glucose utilization.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 3. Mitochondrial dysfunction: Cause or consequence of metabolic disease?
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“At a constant work rate, provision of fatty acids inhibits glycolytic flux and glucose oxidation because the lipid substrate provides at least some portion of the acetyl-CoA that feeds the TCA cycle.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 3. Mitochondrial dysfunction: Cause or consequence of metabolic disease?
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 43
- Probably not a substantial claim. 14
Every source the paper cites for this claim was checked and supports it.
In the paper
“feeding rats a diet enriched with both fat and branched chain amino acids caused insulin resistance in association with elevated intramuscular levels of both even and odd chain acylcarnitine metabolites [64].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 4. Fat oxidation: Friend or foe?
What the sources say
- Supportedcites [64] Newgard, 2009, A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance, Cell Metab. source
The Results section reports that rats fed the high-fat/BCAA diet were insulin resistant after 15 weeks. The Discussion reports accumulation of even-chain acylcarnitines in skeletal muscle, along with C3 and C5 acylcarnitines (odd-chain species), in those rats. (LLM, conf=0.94)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The past decade of diabetes research has focused heavily on the foregoing scenario, and indeed the model is grounded in strong experimental evidence, albeit largely correlative.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > Abstract
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“This relationship is evident in obese and diabetic humans as well as in several rodent and cell culture models of metabolic disease and/or chronic lipid exposure [3,40,41].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 2. Intramuscular lipids, insulin resistance and the athletes' paradox
What the sources say
- Not checked yetcites [3] An, 2004, Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance, Nat. Med. source
- Not checked yetcites [40] Hulver, 2005, Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans, Cell Metab. source
- Not checked yetcites [41] Hulver, 2003, Skeletal muscle lipid metabolism with obesity, Am. J. Physiol. Endocrinol. Metab. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Interest in this topic grew from numerous reports describing a strong negative association between IMTG content and insulin sensitivity [28].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 2. Intramuscular lipids, insulin resistance and the athletes' paradox
What the sources say
- Not checked yetcites [28] Goodpaster, 2002, Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?, Curr. Diab. Rep. source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“muscle insulin resistance often (but not always [86]) coexists with abnormalities in mitochondrial morphology, reduced NADH:O2 oxidoreductase activity, diminished in vivo rates of ATP synthesis and TCA cycle flux, as well as low expression levels of genes involved in mitochondrial biogenesis and oxidative metabolism [47,49,59,68,78].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 2. Intramuscular lipids, insulin resistance and the athletes' paradox
What the sources say
- Not checked yetcites [47] Kelley, 2002, Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes, Diabetes source
- Not checked yetcites [49] Koves, 2005, Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency, J. Biol. Chem. source
- Not checked yetcites [59] Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat. Genet. source
- Not checked yetcites [68] Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1, Proc. Natl. Acad. Sci. U.S. A. source
- Not checked yetcites [78] Ritov, 2005, Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes, Diabetes source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“the mitochondrial dysfunction theory of insulin resistance predicts that impaired or insufficient mitochondrial uptake and oxidation of fatty acids results in their alternative use as substrates for generating harmful lipid signaling molecules [69].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 2. Intramuscular lipids, insulin resistance and the athletes' paradox
What the sources say
- Not checked yetcites [69] Petersen, 2006, New insights into the pathogenesis of insulin resistance in humans using magnetic resonance spectroscopy, Obesity (Silver Spring) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Under resting conditions ATP demands are low and the ETS operates at only a small fraction of total respiratory capacity.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 3. Mitochondrial dysfunction: Cause or consequence of metabolic disease?
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
It may state two separate claims as one.
In the paper
“This concept conflicts with compelling evidence that fatty acids and glucose compete as metabolic substrates [74].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 3. Mitochondrial dysfunction: Cause or consequence of metabolic disease?
What the sources say
- Not checked yetcites [74] Randle, 1998, Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years, Diabetes Metab. Rev. source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“These traits are most often observed in association with aging, severe obesity and type 2 diabetes but were also evident in young insulin-resistant offspring of parents with diabetes [60,62].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 2. Intramuscular lipids, insulin resistance and the athletes' paradox
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Several of the even chain, fatty acid-derived acylcarnitine intermediates were elevated in muscle of obese rodents, but decreased after a 2-week exercise intervention that restored glucose tolerance.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 4. Fat oxidation: Friend or foe?
What the sources say
- Not checked yetcites [49] Koves, 2005, Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency, J. Biol. Chem. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“skeletal muscles harbor enormous mitochondrial reserve, enabling exponential increases in energy output during vigorous physical activity.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 3. Mitochondrial dysfunction: Cause or consequence of metabolic disease?
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Expanded mitochondrial mass therefore affords the advantage of enhanced fat oxidation during moderate to high intensity exercise but should not have much impact at rest.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 3. Mitochondrial dysfunction: Cause or consequence of metabolic disease?
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“which occurs when carbon flux through the β-oxidation machinery outpaces entry of acetyl-CoA (the final product of β-oxidation) into the TCA cycle.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 4. Fat oxidation: Friend or foe?
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“the mitochondrial dysfunction theory of insulin resistance implies that mitochondrial content and/or capacity dictates resting rates of fat oxidation.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 3. Mitochondrial dysfunction: Cause or consequence of metabolic disease?
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“genetic ablation of Nur77, a transcriptional regulator of glucose utilization genes in skeletal muscle, increased susceptibility to diet-induced obesity and insulin resistance in parallel with elevated IMTG content and accumulation of even-chained acylcarnitine species [18].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 4. Fat oxidation: Friend or foe?
What the sources say
- Not checked yetcites [18] Chao, 2009, Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77, Diabetes source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“insulin resistant states were marked by increased whole body fat oxidation, impaired switching to carbohydrate substrate during the fasted to fed transition, and coincident reductions in muscle levels of several TCA cycle intermediates [50].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 4. Fat oxidation: Friend or foe?
What the sources say
- Not checked yetcites [50] Koves, 2008, Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance, Cell Metab. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“A similar phenotype was reported as a consequence of muscle-specific deletion of apoptosis inducing factor (AIF), a protein that plays a key role in regulating the ETS [70].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 5. Mitochondrial dysfunction and insulin resistance: A matter of definition?
What the sources say
- Not checked yetcites [70] Pospisilik, 2007, Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes, Cell source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Considering that a moderate to severe deficit in mitochondrial function increases reliance on glycolytic metabolism, it is not so surprising that these genetic maneuvers elicited adaptations that enhance glucose uptake and insulin sensitivity.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 5. Mitochondrial dysfunction and insulin resistance: A matter of definition?
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although emerging reports appear to argue against a role for mitochondrial dysfunction as a root cause of muscle insulin resistance, the controversy might come down to a matter of definition.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 5. Mitochondrial dysfunction and insulin resistance: A matter of definition?
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“lowering of MCD activity in primary human skeletal myocytes using small interfering RNAs invoked a clear shift from fatty acid to glucose oxidation and a corresponding increase in both basal and insulinstimulated glucose uptake [13].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 4. Fat oxidation: Friend or foe?
What the sources say
- Not checked yetcites [13] Bouzakri, 2008, Malonyl coenzyme A decarboxylase regulates lipid and glucose metabolism in human skeletal muscle, Diabetes source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“in contrast to the diabetic subjects, AIF null mice maintained insulin sensitivity and resisted the diabetogenic effects of a high fat diet.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 5. Mitochondrial dysfunction and insulin resistance: A matter of definition?
What the sources say
- Not checked yetcites [70] Pospisilik, 2007, Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes, Cell source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“the mcd−/− mice had decreased acylcarnitine accumulation in muscle, enhanced rates of glucose oxidation, and resisted diet-induced glucose intolerance, despite high intramuscular levels of triacylglycerol and long chain acyl-CoAs [50,88].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 4. Fat oxidation: Friend or foe?
What the sources say
- Not checked yetcites [50] Koves, 2008, Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance, Cell Metab. source
- Not checked yetcites [88] Ussher, 2009, Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase, Diabetes source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“mice lacking the mitochondrial transcription factor A (TFAM) have reduced oxidative capacity but increased whole body glucose tolerance and enhanced insulin-stimulated glucose uptake in isolated muscles [95].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 5. Mitochondrial dysfunction and insulin resistance: A matter of definition?
What the sources say
- Not checked yetcites [95] Wredenberg, 2006, Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance, Biochem. Biophys. Res. Commun. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“a broader interpretation of mitochondrial dysfunction encompasses perturbations that do not necessarily compromise oxidative potential. Thus, disturbances in mitochondrial fuel selection, anaplerotic and cataplerotic carbon flux, redox balance and production of reactive oxygen species (ROS) can occur in the absence of measurable defects in respiratory capacity [4,12,65].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 5. Mitochondrial dysfunction and insulin resistance: A matter of definition?
What the sources say
- Not checked yetcites [4] Anderson, 2009, Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans, J. Clin. Invest. source
- Not checked yetcites [12] Boucher, 2004, Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue, J. Biol. Chem. source
- Not checked yetcites [65] Noland, 2009, Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control, J. Biol. Chem. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“These outcomes were associated with increased cell surface levels of the GLUT-4 glucose transporter, but surprisingly no enhancement in insulin signaling at the levels of IRS-1 tyrosine phosphorylation, PI3-kinase activity, or serine phosphorylation of Akt.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 4. Fat oxidation: Friend or foe?
What the sources say
- Not checked yetcites [13] Bouzakri, 2008, Malonyl coenzyme A decarboxylase regulates lipid and glucose metabolism in human skeletal muscle, Diabetes source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“whole body or muscle-specific deletion of the redox regulatory protein, thioredoxin interaction protein (TXNIP), resulted in impaired oxidative muscle metabolism while also producing mice that were exquisitely insulin responsive, even after high fat feeding [38].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 5. Mitochondrial dysfunction and insulin resistance: A matter of definition?
What the sources say
- Not checked yetcites [38] Hui, 2008, Txnip balances metabolic and growth signaling via PTEN disulfide reduction, Proc. Natl. Acad. Sci. U.S.A. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, in theory, a surplus of both glucose and lipid fuel should raise mitochondrial membrane potential.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 5. Mitochondrial dysfunction and insulin resistance: A matter of definition?
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“persistently high rates of fat oxidation might foster a mitochondrial microenvironment that is conducive to ROS production.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 5. Mitochondrial dysfunction and insulin resistance: A matter of definition?
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“When energy delivery is high (overfeeding) but ATP consumption is low (physical inactivity), a high ATP/ADP ratio reduces proton flux through ATP synthase and slows electron transport through the ETS.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 5. Mitochondrial dysfunction and insulin resistance: A matter of definition?
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“These conditions increase mitochondrial membrane potential and the local ratio of NADH/NAD, which in turn imposes negative pressure on several TCA cycle enzymes.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 5. Mitochondrial dysfunction and insulin resistance: A matter of definition?
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In both rodents and humans insulin resistant states were associated with increased mitochondrial H2O2 emission potential and decreased skeletal muscle levels of glutathione, a commonly used biomarker of oxidative/reductive stress due to its important role in detoxifying H2O2 [4].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 5. Mitochondrial dysfunction and insulin resistance: A matter of definition?
What the sources say
- Not checked yetcites [4] Anderson, 2009, Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans, J. Clin. Invest. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Patients afflicted with these disorders present with nonketotic hypoglycemia, muscle weakness, pronounced elevations in long chain acylcarnitines and systemic carnitine depletion [91].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 6. Carnitine as an antilipotoxic therapy
What the sources say
- Not checked yetcites [91] Wanders, 1999, Disorders of mitochondrial fatty acyl-CoA beta-oxidation, J. Inherit. Metab. Dis. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Clearly, exercise-induced mitochondrial adaptations and fiber type switching contribute to improved fitness and athletic performance; however, their presumed roles in combating obesity and diabetes are still based on circumstantial evidence.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Both of these transgenic mouse models had increased expression of multiple mitochondrial proteins, leading to enhanced capacity for fat oxidation, but contrary to the predicted outcome they were more susceptible to whole body and skeletal muscle insulin resistance.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [19] Choi, 2008, Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism, Proc. Natl. Acad. Sci. U.S.A. source
- Not checked yetcites [24] Finck, 2005, A potential link between muscle peroxisome proliferator-activated receptor-a signaling and obesity-related diabetes, Cell Metab. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Much attention has centered on mitochondrial biogenesis and concomitant enhancement of oxidative capacity, both of which represent hallmark adaptations that occur in response to aerobic exercise training and coincide with insulin sensitization [35].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [35] Holloszy, 1984, Adaptations of skeletal muscle to endurance exercise and their metabolic consequences, J. Appl. Physiol. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The obesity-related decline in free carnitine was associated with increased whole body fat oxidation, muscle accumulation of long chain acylcarnitines, a corresponding decline in short chain acylcarnitine species, and impaired substrate switching from fatty acid to pyruvate when measured in isolated mitochondria.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 6. Carnitine as an antilipotoxic therapy
What the sources say
- Not checked yetcites [65] Noland, 2009, Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control, J. Biol. Chem. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This metabolite derives from acetyl-CoA via the action of carnitine acetyltransferase (CrAT), a mitochondrial enzyme that converts short chain CoA species to their acylcarnitine counterparts while also regenerating free CoA [21].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 6. Carnitine as an antilipotoxic therapy
What the sources say
- Not checked yetcites [21] Cordente, 2004, Redesign of carnitine acetyltransferase specificity by protein engineering, J. Biol. Chem. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“carnitine therapy improved glucose tolerance and insulin responsiveness in rodent models of aging, genetic diabetes and high fat feeding [65,71], while also reversing obesity-related derangements in mitochondrial fuel selection [65].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 6. Carnitine as an antilipotoxic therapy
What the sources say
- Not checked yetcites [65] Noland, 2009, Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control, J. Biol. Chem. source
- Not checked yetcites [71] Power, 2007, Carnitine revisited: potential use as adjunctive treatment in diabetes, Diabetologia source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“l-carnitine is an FDA-approved therapy for inborn errors in metabolism [56].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 6. Carnitine as an antilipotoxic therapy
What the sources say
- Not checked yetcites [56] Longo, 2006, Disorders of carnitine transport and the carnitine cycle, Am. J. Med. Genet. C. Semin. Med. Genet. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The salutary impact of physical activity on insulin sensitivity, and metabolic health in general, has been well recognized for decades.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The MCK-PGC1α transgene caused a 2.4-fold increase in mitochondrial content of type II fibers without affecting type I fibers [19].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [19] Choi, 2008, Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism, Proc. Natl. Acad. Sci. U.S.A. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In the MCK-PPARα mice, administration of oxfenicine, a pharmacological inhibitor of β-oxidation, improved glucose tolerance, suggesting excessive fat oxidation contributed to the diabetic phenotype [24].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [24] Finck, 2005, A potential link between muscle peroxisome proliferator-activated receptor-a signaling and obesity-related diabetes, Cell Metab. source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The resulting boost in oxidative power enabled superior exercise performance relative to wild-type mice [15] but did not change fat mass, total body energy expenditure or weight gain during a high fat diet.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [15] Calvo, 2008, Muscle-specific expression of PPARgamma coactivator-1alpha improves exercise performance and increases peak oxygen uptake, J. Appl. Physiol. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Equally plausible however, the combined increases in IMTG and mitochondrial content may have encouraged preferential oxidation of lipid substrate, thereby antagonizing the drive for glucose uptake and utilization as predicted by the Randle hypothesis.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Both acute and chronic exercise induce muscle expression of glycerolipid biosynthetic enzymes, which is coupled to increased IMTG synthesis and content [42,80].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [42] Ikeda, 2002, Up-regulation of SREBP-1c and lipogenic genes in skeletal muscles after exercise training, Biochem. Biophys. Res. Commun. source
- Not checked yetcites [80] Schenk, 2007, Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance, J. Clin. Invest. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Interestingly however, DGAT1 overexpression was also accompanied by a complex set of mitochondrial abnormalities, including altered morphology, a 45% reduction in mtDNA and increased mRNA expression of metabolic genes such as CPT1 and uncoupling protein 3 [53].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [53] Liu, 2009, Paradoxical coupling of triglyceride synthesis and fatty acid oxidation in skeletal muscle overexpressing DGAT1, Diabetes source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The study implies that sequestration of fatty acid into IMTG guards against less desirable fates.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“A recent study in humans showed that the insulin sensitizing properties of a single exercise session corresponded with elevated IMTG content and lower muscle levels of DAG, ceramide and muscle glycogen, all measured the day after exercise and following a lipid perfusion [80].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [80] Schenk, 2007, Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance, J. Clin. Invest. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, these findings revealed a strong association between improved insulin action and enhanced mitochondrial activity, but without corresponding reductions in leading candidate mediators of insulin resistance.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In line with this scenario, contraction caused a robust reduction in IMTG content of the obese muscles; however, diacylglycerol, monoacylglycerol and long chain acyl-CoAs were either unchanged or increased.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [83] Thyfault, 2007, Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism, Am. J. Physiol. Cell Physiol. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In this investigation the experimental protocol resulted in decreased glycogen levels but did not affect IMTG levels.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [25] Frosig, 2009, Reduced malonyl-CoA content in recovery from exercise correlates with improved insulin-stimulated glucose uptake in human skeletal muscle, Am. J. Physiol. Endocrinol. Metab. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Analysis of mitochondrial-derived acylcarnitines showed that the contraction regimen elicited marked increases in β-oxidation and mitochondrial carbon flux, in parallel with reduced malonyl-CoA levels.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [83] Thyfault, 2007, Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism, Am. J. Physiol. Cell Physiol. source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Both the endogenous supply and mitochondrial use of fatty acid substrate appeared to be greater in muscle from the obese versus lean rats, despite similar rates of glycogen depletion.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [83] Thyfault, 2007, Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism, Am. J. Physiol. Cell Physiol. source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Deficiency of ATGL in whole body knockout mice results in severe metabolic disruptions, cardiac dysfunction and premature death [29], which occurs in association with increased tissue lipid droplet accumulation, decreased DAG and ceramide levels, and inhibition of both fatty acid oxidation and mRNA expression of oxidative genes.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [29] Haemmerle, 2006, Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase, Science source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Deficiency of ATGL in whole body knockout mice results in severe metabolic disruptions, cardiac dysfunction and premature death [29], which occurs in association with increased tissue lipid droplet accumulation, decreased DAG and ceramide levels, and inhibition of both fatty acid oxidation and mRNA expression of oxidative genes.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [29] Haemmerle, 2006, Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase, Science source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Still, the animal models permit proof-of-concept experiments that are difficult, or even impossible, to accomplish in humans.”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 8. Summary and concluding remarks
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“As a result, these mice exhibit increased glucose use, depleted liver and muscle glycogen levels, and enhanced whole body and skeletal muscle insulin sensitivity [29,39,48].”
§ Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? > 7. Exercise as an antilipotoxic strategy
What the sources say
- Not checked yetcites [29] Haemmerle, 2006, Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase, Science source
- Not checked yetcites [39] Huijsman, 2009, Adipose triacylglycerol lipase deletion alters whole body energy metabolism and impairs exercise performance in mice, Am. J. Physiol. Endocrinol. Metab. source
- Not checked yetcites [48] Kienesberger, 2009, Adipose triglyceride lipase deficiency causes tissue-specific changes in insulin signaling, J. Biol. Chem. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
At least part of the health benefit of routine physical activity comes from redistribution of body fat and adjustments in whole-body lipid balance.
“It is also likely that at least some of this benefit is secondary to redistribution of body fat and adjustments in whole body lipid balance.”
The paper relies on this without support.
Few studies have directly examined contraction-induced reversal of insulin resistance alongside global changes in muscle lipid metabolites.
“However, few studies have directly examined contraction-induced reversal of insulin resistance in accord with global changes in muscle lipid metabolites.”
The paper relies on this without support.
Muscle contraction increases mitochondrial flux and degradation of carbon substrates, including fatty acids.
“Clearly, muscle contraction increases mitochondrial flux and degradation of carbon substrates, including but not limited to fatty acids.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As anticipated these mice have severely compromised oxidative performance, but contrary to the predicted development of insulin resistance, many of these transgenic models display increased insulin sensitivity relative to wild type mice, even when challenged with a fat-enriched diet (reviewed in (Muoio, 2010)).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Muoio, 2010
In the citing paper
“FAO intermediates may also create an unfavorable environment in the mitochondria, which contributes to the formation of ROS and the development of oxidative stress ([119](#B119), [120](#B120)).”
From Mitochondrial fatty acid oxidation in obesity (2013) · cites this paper as [119]
Citations
Cites
1 retracted
Watt, M. J., van Denderen, B. J. W., Castelli, L. A., Bruce, C. R., Hoy, A. J., Kraegen, E. W., Macaulay, L. S., & Kemp, B. E. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0485 · Cited by 37
RetractedMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525 · cited 2×
“Likewise, experiments in cultured 3T3-L1 adipocytes showed that several distinct genetic and nutritional maneuvers that reduced oxidative stress blocked insulin resistance caused by dexamethasone and TNFα [36].”
BackgroundDysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990
Self-citationAdaptations of skeletal muscle to endurance exercise and their metabolic consequences
Holloszy, J. O., & Coyle, E. F. (1984) · Journal of Applied Physiology · doi:10.1152/jappl.1984.56.4.831 · Cited by 1,985
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase
Haemmerle, G., Lass, A., Zimmermann, R., Gorkiewicz, G., Meyer, C., Rozman, J., Heldmaier, G., Maier, R., Theussl, C., Eder, S., et al. (2006) · Science · doi:10.1126/science.1123965 · Cited by 1,375
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253
Research works printed but not linked: 1
- Longo, 2006, Disorders of carnitine transport and the carnitine cycle, Am. J. Med. Genet. C. Semin. Med. Genet., 142C, 77, 10.1002/ajmg.c.30087 · DOI · Paper page
Cited by
Sorted by citations
Cusi, K. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.003 · Cited by 940
Mechanisms of insulin resistance in obesity
Ye, J. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0262-6 · Cited by 699
Insulin Resistance, Obesity and Lipotoxicity
Yazıcı, D., & Sezer, H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_12 · Cited by 525
Muoio, D. M., Noland, R. C., Kovalik, J.-P., Seiler, S. E., Davies, M. N., DeBalsi, K. L., Ilkayeva, O. R., Stevens, R. D., Kheterpal, I., Zhang, J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.005 · Cited by 372
Self-citationRenal lipid metabolism and lipotoxicity
Bobulescu, I. A. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32833aa4ac · Cited by 377
Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle
Muoio, D. M., & Neufer, P. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.010 · Cited by 343
Self-citationYamamoto, T., Takabatake, Y., Takahashi, A., Kimura, T., Namba‐Hamano, T., Matsuda, J., Minami, S., Kaimori, J., Matsui, I., Matsusaka, T., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016070731 · Cited by 311
Kimmel, A. R., & Sztalryd, C. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071813-105410 · Cited by 297
Mitochondrial fatty acid oxidation in obesity
Serra, D., Mera, P., Malandrino, M. I., Mir, J. F., & Herrero, L. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4875 · Cited by 246
Lepretti, M., Martucciello, S., Burgos Aceves, M., Putti, R., & Lionetti, L. (2018) · Nutrients · doi:10.3390/nu10030350 · Cited by 232
Intrahepatic Diacylglycerol Content Is Associated With Hepatic Insulin Resistance in Obese Subjects
Magkos, F., Su, X., Bradley, D. P., Fabbrini, E., Conte, C., Eagon, J. C., Varela, J. E., Brunt, E. M., Patterson, B. W., & Klein, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.003 · Cited by 223
From OCR and ECAR to energy: Perspectives on the design and interpretation of bioenergetics studies
Schmidt, C. A., Fisher‐Wellman, K. H., & Neufer, P. D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101140 · Cited by 206
Krause, M. P., Riddell, M. C., & Hawke, T. J. (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00699.x · Cited by 190
Morris, E. M., Meers, G. M.-E., Booth, F. W., Fritsche, K. L., Hardin, C. D., Thyfault, J. P., & Ibdah, J. A. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00169.2012 · Cited by 186
Pathogenesis of MASLD and MASH – role of insulin resistance and lipotoxicity
Bansal, S., & Bansal, M. B. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17930 · Cited by 211
Targeting fatty acid metabolism to improve glucose metabolism
Stinkens, R., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2015) · Obesity Reviews · doi:10.1111/obr.12298 · Cited by 183
Of mice and men: The physiological role of adipose triglyceride lipase (ATGL)
Schreiber, R., Xie, H., & Schweiger, M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.10.008 · Cited by 178
Sztalryd, C., & Kimmel, A. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.026 · Cited by 158
Meng, Z.-X., Li, S., Wang, L., Ko, H. J., Lee, Y., Jung, D. Y., Okutsu, M., Yan, Z., Kim, J. K., & Lin, J. D. (2013) · Nature Medicine · doi:10.1038/nm.3144 · Cited by 146
Kien, C. L., Bunn, J. Y., Poynter, M. E., Stevens, R., Bain, J. R., IIkayeva, O., Fukagawa, N. K., Champagne, C. M., Crain, K. I., Koves, T. R., et al. (2012) · Diabetes · doi:10.2337/db12-0363 · Cited by 138
Self-citationThe relationship between phospholipids and insulin resistance: From clinical to experimental studies
Chang, W., Hatch, G. M., Wang, Y., Yu, F., & Wang, M. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13984 · Cited by 143
Bosma, M., Sparks, L. M., Hooiveld, G. J. E. J., Jörgensen, J. A., Houten, S. M., Schrauwen, P., Kersten, S., & Hesselink, M. K. C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.01.007 · Cited by 135
Wu, W.-C., Feng, J., Jiang, D., Zhou, X., Jiang, Q. L., Cai, M., Wang, X., Shan, T., & Wang, Y. (2017) · Scientific Reports · doi:10.1038/srep41606 · Cited by 119
Brøns, C., & Grunnet, L. G. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0488 · Cited by 114
Ceccarelli, S. M., Chomienne, O., Gubler, M., & Arduini, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100809g · Cited by 111
Muscle insulin resistance: assault by lipids, cytokines and local macrophages
Kewalramani, G., Bilan, P. J., & Klip, A. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833aabd9 · Cited by 105
Impact of Lipids on Insulin Resistance: Insights from Human and Animal Studies
Elkanawati, R. Y., Sumiwi, S. A., & Levita, J. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s468147 · Cited by 110
Defect of insulin signal in peripheral tissues: Important role of ceramide
Hassan, R. H. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i3.244 · Cited by 97
Labbé, S. M., Grenier–Larouche, T., Croteau, É., Normand-Lauzière, F., Frisch, F., Ouellet, R., Guérin, B., Turcotte, É. E., & Carpentier, A. C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00579.2010 · Cited by 90
Putti, R., Migliaccio, V., Sica, R., & Lionetti, L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2015.00426 · Cited by 94
Coletta, D. K., & Mandarino, L. J. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00363.2011 · Cited by 90
Hirahatake, K. M., Slavin, J. L., Maki, K. C., & Adams, S. H. (2014) · Metabolism · doi:10.1016/j.metabol.2014.02.009 · Cited by 89
Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance
Lipina, C., & Hundal, H. S. (2011) · Diabetologia · doi:10.1007/s00125-011-2127-3 · Cited by 83
Triglycerides in the Human Kidney Cortex: Relationship with Body Size
Bobulescu, I. A., Lotan, Y., Zhang, J.-N., Rosenthal, T., Rogers, J., Adams-Huet, B., Sakhaee, K., & Moe, O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101285 · Cited by 72
Oxidative tissue: perilipin 5 links storage with the furnace
Wang, H., & Sztalryd, C. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.03.008 · Cited by 79
Impact of Adipose Tissue and Lipids on Skeletal Muscle in Sarcopenia
Jang, S. Y., & Choi, K. M. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70000 · Cited by 81
Leskinen, T., Rinnankoski-Tuikka, R., Rintala, M., Seppänen-Laakso, T., Pöllänen, E., Alen, M., Sipilä, S., Kaprio, J., Kovanen, V., Rahkila, P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012609 · Cited by 75
Metabolic Flexibility and Its Impact on Health Outcomes
Palmer, B. F., & Clegg, D. J. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.01.012 · Cited by 84
Mitochondrial involvement in skeletal muscle insulin resistance: A case of imbalanced bioenergetics
Affourtit, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.07.008 · Cited by 67
Glucose Sensing by Skeletal Myocytes Couples Nutrient Signaling to Systemic Homeostasis
Meng, Z., Gong, J., Chen, Z., Sun, J., Xiao, Y., Wang, L., Li, Y., Liu, J., Xu, X., & Lin, J. D. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.04.007 · Cited by 69
Insulin Resistance, Obesity, and Lipotoxicity
Yazıcı, D., Demir, S. Ç., & Sezer, H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_14 · Cited by 85
Zeng, X., Wang, H., Bai, F., Zhou, X., Li, S., Ren, L., Sun, R., Xue, C. C., Jiang, H., Hu, L., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13209 · Cited by 70
Mechanism of insulin resistance in obesity: a role of ATP
Ye, J. (2021) · Frontiers of Medicine · doi:10.1007/s11684-021-0862-5 · Cited by 70
Mullins, G. R., Wang, L., Raje, V., Sherwood, S. G., Grande, R. C., Boroda, S., Eaton, J. M., Blancquaert, S., Roger, P. P., Leitinger, N., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410530111 · Cited by 75
Kemp, G. J., & Brindle, K. M. (2012) · Diabetes · doi:10.2337/db11-1725 · Cited by 71
Raddatz, K., Turner, N. A., Frangioudakis, G., Liao, B. M., Pedersen, D. J., Cantley, J., Wilks, D. L., Preston, E., Hegarty, B. D., Leitges, M., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2073-0 · Cited by 69
Intrinsic aerobic capacity impacts susceptibility to acute high-fat diet-induced hepatic steatosis
Morris, E. M., Jackman, M. R., Johnson, G. C., Cross, T.-W., Lopez, J. L., Kearney, M. L., Fletcher, J. A., Meers, G. M.-E., Koch, L. G., Britton, S. L., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00093.2014 · Cited by 69
Abnormal Myocardial Dietary Fatty Acid Metabolism and Diabetic Cardiomyopathy
Carpentier, A. C. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.029 · Cited by 66
Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep
Duckett, S. K., Lagreca, G. V., Alende, M., & Long, N. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s72695 · Cited by 59
Huang, Y., Gao, S., Chen, J., Albrecht, E., Zhao, R., & Yang, X. (2016) · Oncotarget · doi:10.18632/oncotarget.14375 · Cited by 59
Schwenk, R. W., Angın, Y., Steinbusch, L. K. M., Dirkx, E., Hoebers, N., Coumans, W. A., Bonen, A., Broers, J. L. V., van Eys, G. J. J. M., Glatz, J. F. C., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.363630 · Cited by 56
Rogowski, M. P., Flowers, M. T., Stamatikos, A., Ntambi, J. M., & Paton, C. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035865 · Cited by 55
Skeletal Muscle and Bone – Emerging Targets of Fibroblast Growth Factor-21
Sun, H., Sherrier, M. C., & Li, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.625287 · Cited by 54
Lipid signals and insulin resistance
Zhang, C., Klett, E. L., & Coleman, R. (2013) · Clinical Lipidology · doi:10.2217/clp.13.67 · Cited by 58
Zhao, L., Zou, T., Gomez, N. A., Wang, B., Zhu, M. J., & Du, . (2018) · Nutrition and Diabetes · doi:10.1038/s41387-018-0049-6 · Cited by 54
Role of nuclear receptor corepressor RIP140 in metabolic syndrome
Rosell, M., Jones, M. C., & Parker, M. G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.016 · Cited by 53
Fibroblast Growth Factor 21 Suppresses Adipogenesis in Pig Intramuscular Fat Cells
Wang, Y., Liu, X., Hou, L., Wu, W., Zhao, S., & Xiong, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010011 · Cited by 52
Kahn, H. S., Bullard, K. M., Barker, L. E., & Imperatore, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050428 · Cited by 51
Pinel, A., Morio, B., & Capel, F. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0303-2 · Cited by 50
Polonsky, K. S., & Burant, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00031-9 · Cited by 53
Brockman, D. A., Chen, X., & Gallaher, D. D. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-100 · Cited by 46
WAT is a functional adipocyte?
CHURCH, C. D., Horowitz, M. C., & Rodeheffer, M. S. (2012) · Adipocyte · doi:10.4161/adip.19132 · Cited by 49
Muoio, D. M. (2012) · Diabetologia · doi:10.1007/s00125-012-2597-y · Cited by 44
Self-citationCoudray, C., Fouret, G., Lambert, K., Ferreri, C., Rieusset, J., Błachnio-Zabielska, A. U., Lecomte, J., Elle, R. E., Badia, É., Murphy, M. P., et al. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114515005528 · Cited by 44
Jana, B. A., Chintamaneni, P. K., Krishnamurthy, P. T., Wadhwani, A., & Mohankumar, S. K. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4551-7 · Cited by 45
Obesity-related insulin resistance: implications for the surgical patient
Tewari, N., Awad, S., Macdonald, I. A., & Lobo, D. N. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.100 · Cited by 40
Accumulation of saturated intramyocellular lipid is associated with insulin resistance
Savage, D. B., Watson, L. P. E., Carr, K., Adams, C., Brage, S., Chatterjee, K., Hodson, L., Boesch, C., Kemp, G. J., & Sleigh, A. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m091942 · Cited by 42
Mthembu, S. X. H., Mazibuko-Mbeje, S. E., Ziqubu, K., Nyawo, T. A., Obonye, N., Nyambuya, T. M., Nkambule, B. B., Silvestri, S., Tiano, L., Muller, C. J. F., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120467 · Cited by 42
Morris, E. M., Meers, G. M.-E., Koch, L. G., Britton, S. L., Fletcher, J. A., Fu, X., Shankar, K., Burgess, S. C., Ibdah, J. A., Rector, R. S., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2016 · Cited by 39
Sayers, A. E., Lawlor, D. A., Sattar, N. A., & Tobias, J. H. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1467 · Cited by 38
Insulin Resistance and Obesity Affect Lipid Profile in the Salivary Glands
Matczuk, J., Zalewska, A., Łukaszuk, B., Knaś, M., Maciejczyk, M., Garbowska, M., Ziembicka, D., Waszkiel, D., Chabowski, A., Żendzian‐Piotrowska, M., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/8163474 · Cited by 38
Hoeks, J., Mensink, M., Hesselink, M. K. C., Ekroos, K., & Schrauwen, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1884 · Cited by 37
Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment,
Chevalier, S., & Farsijani, S. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2013-0369 · Cited by 36
Guitart, M., Osorio-Conles, Ó., Pentinat, T., Cebrià, J., García‐Villoria, J., Sala, D., Sebastián, D., Zorzano, A., Ribes, A., Jiménez‐Chillarón, J. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098109 · Cited by 32
Nielsen, M. H., Sabaratnam, R., Pedersen, A. J. T., Højlund, K., & Handberg, A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02547 · Cited by 30
Park, M., Kim, K. H., Jaiswal, V. K., Choi, J., Chun, J. L., Seo, K., Lee, M.-J., & Lee, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-95789-8 · Cited by 29
Exercise improves metabolic function and alters the microbiome in rats with gestational diabetes
Mahizir, D., Briffa, J. F., Wood, J. L., Anevska, K., Hill‐Yardin, E. L., Jefferies, A. J., Gravina, S., Mazzarino, G., Franks, A. E., Moritz, K. M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901424r · Cited by 29
Meng, Z., Tao, W., Sun, J., Wang, Q., Mi, L., & Lin, J. D. (2017) · Diabetes · doi:10.2337/db17-0367 · Cited by 28
Targeting mitochondrial transporters and metabolic reprogramming for disease treatment
Anselme, M., He, H., Lai, C., Luo, W., & Zhong, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06976-4 · Cited by 33
Buse, J. B., Polonsky, K. S., & Burant, C. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00031-6 · Cited by 28
Grenier–Larouche, T., Carreau, A., & Carpentier, A. C. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.10.013 · Cited by 26
Smith, C. D., Lin, C., McMillin, S. L., Weyrauch, L. A., Schmidt, C. A., Smith, C. A., Kurland, I. J., Witczak, C. A., & Neufer, P. D. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00010.2021 · Cited by 25
Holloway, G. P., Han, X., Jain, S. S., Bonen, A., & Chabowski, A. (2014) · Diabetologia · doi:10.1007/s00125-014-3169-0 · Cited by 28
PKCε regulates contraction‐stimulated GLUT4 traffic in skeletal muscle cells
Niu, W., Bilan, P. J., Yu, J., Gao, J., Boguslavsky, S., Schertzer, J. D., Chu, G., Yao, Z., & Klip, A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22320 · Cited by 24
Gillingham, M. B., Harding, C. O., Schoeller, D. A., Matern, D., & Purnell, J. Q. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00225.2013 · Cited by 25
Almeda‐Valdés, P., Gómez‐Velasco, D., Arellano‐Campos, O., Bello‐Chavolla, O. Y., Sevilla-González, M. D. R., Viveros-Ruiz, T. L., Martagón, A. J., Bautista, C. J., Muñóz-Hernández, L. L., Cruz‐Bautista, I., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0677 · Cited by 26
Skeletal muscle lipid flux: running water carries no poison
Funai, K., & Semenkovich, C. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00152.2011 · Cited by 24
Deere, K. C., Sayers, A. E., Viljakainen, H. T., Lawlor, D. A., Sattar, N. A., Kemp, J. P., Fraser, W. D., & Tobias, J. H. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1272 · Cited by 23
Nomikos, T., Methenitis, S., & Panagiotakos, D. B. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01692-0 · Cited by 23
Subcellular lipid droplet distribution in red and white muscles in the obese Zucker rat
Lally, J., Snook, L. A., Han, X., Chabowski, A., Bonen, A., & Holloway, G. P. (2011) · Diabetologia · doi:10.1007/s00125-011-2367-2 · Cited by 22
Therapeutic potential of antisense oligonucleotides for the management of dyslipidemia
Carpentier, A. C., Labbé, S. M., Grenier–Larouche, T., & Noll, C. (2011) · Clinical Lipidology · doi:10.2217/clp.11.60 · Cited by 23
Sun, Y., Yang, Z.-X., Ren, F., & Fang, B. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.04.186 · Cited by 22
Metabolic Dysfunction in Diabetic Offspring
Russell, R., Kraemer, R. R., & Nelson, A. G. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31826909d3 · Cited by 22
Mitochondrial regulation of insulin action
Murrow, B. A., & Hoehn, K. L. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.020 · Cited by 20
Tucci, S., Flögel, U., & Spiekerkoetter, U. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.009 · Cited by 19
Grenier–Larouche, T., Labbé, S. M., Noll, C., Richard, D., & Carpentier, A. C. (2012) · International Journal of Obesity Supplements · doi:10.1038/ijosup.2012.21 · Cited by 17
Watt, M. J. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-019 · Cited by 18
Bahn, Y. J., Yadav, H., Piaggi, P., Abel, B. S., Gavrilova, O., Springer, D., Papazoglou, I., Zerfas, P. M., Skarulis, M. C., McPherron, A. C., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162479 · Cited by 19
Urrutia, R. A., & Kalinec, F. (2015) · Hearing Research · doi:10.1016/j.heares.2015.04.015 · Cited by 17
Bioactive compounds from Artemisia dracunculus L. activate AMPK signaling in skeletal muscle
Vandanmagsar, B., Yu, Y., Simmler, C., Dang, T. N., Kuhn, P. E., Poulev, A., Ribnicky, D., Pauli, G. F., & Floyd, Z. E. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112188 · Cited by 17
Metadata
- Authors
- Muoio, D. M.
- Affiliations
- Duke University (US)
- Corresponding author
- Muoio, Deborah M.
- ORCID
- Muoio, Deborah M.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 1801
- Issue
- 3
- Pages
- 281-288
- ISSN
- 1388-1981 (ISSN-L)
- PMC
- PMC4428562
- OpenAlex
- W2055517980
- Cited by
- 137
- References
- 97
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 8 · 2020: 2 · 2019: 4 · 2018: 8 · 2017: 7 · 2016: 13 · 2015: 11 · 2014: 9 · 2013: 15 · 2012: 21
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- National Institute on Aging (R01AG028930, P30AG028716)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056112, K01-DK56112, K01DK067200, R01DK089312)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- insulin resistance, lipotoxicity, skeletal muscle, lipid oxidation, physical activity, ceramide, diacylglycerol, serine kinase, insulin signaling, lipid metabolism
- MeSH terms
- Animals, Carnitine, Disease Models, Animal, Humans, Insulin Resistance, Triglycerides, Lipid Peroxidation, Exercise, Muscle, Skeletal, Mitochondrial Diseases, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review